Acute mountain sickness is caused by sub-acute hypoxia in healthy individuals going rapidly to altitude. Both tissue hypoxia in vitro and whole-body hypoxia in vivo have been found to promote the release of reactive oxygen species. Nitronyl nitroxide can trap free radicals such as ·NO or ·OH, and may therefore be efficient protective agents. This study assessed the ability of nitronyl nitroxide to against acute mountain sickness as a free radical scavenger in acute high-altitude hypoxia mice model. Normobaric hypoxia and hypobaric hypoxia model were used to estimate the protect effects of nitronyl nitroxide against acute mountain sickness. Low pressure oxygen compartment system was used to stimulate high-altitude hypobaric hypoxia environment. Mice in nitronyl nitroxide groups survived longer than acetazolamide group in normobaric hypoxia test. Hydrogen peroxide (H 2 O 2 ) and malondialdehyde (MDA) increased in both cerebrum and myocardium in vehicle group. The results indicated more radicals were generated during high-altitude hypobaric hypoxia environment. In therapeutic groups H 2 O 2 and MDA were significantly reduced while the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) were similar to normal group. These results demonstrated that nitronyl nitroxide was an efficient tissue radical scavenger and a potential protective agent for acute mountain sickness.Key words nitronyl nitroxide; antioxidant; free radical scavenger; acute high-altitude hypoxia More than 140 million people worldwide live >2500 m above sea level. Eighty million live in Asia, and 35 million live in the Andean mountains. The latter region has its major population density living above 3500 m.1) Barometric pressure falls with increasing altitude and consequently in the partial pressure of oxygen reduced. This leads to a hypoxic challenge to any individual ascending to altitude. A spectrum of highaltitude illnesses can occur when the hypoxic stress outstrips the subject's ability to acclimatize.2) Acute mountain sickness (AMS) is a condition affecting otherwise healthy individuals going rapidly to altitude. It is caused by sub-acute hypoxia in susceptible subjects.3) Acute hypoxia induces pulmonary vascular permeability and contributes to forms of noncardiogenic pulmonary edema such as high-altitude pulmonary edema and acute respiratory distress syndrome.4,5) AMS can sharply limit people's recreation and working at high altitude, especially in the first few days following arrival at a new, higher altitude.
6)More and more studies were concerned on the prophylaxis and therapy of AMS.
7-9)In vitro hypoxia and in vivo whole-body hypoxia can cause tissue release reactive oxygen species (ROS) which are potentially damaging to the cardiovascular system. 10) Hypoxia rapidly increases the levels of free radicals in organism, which is thought to overwhelm the reserves of scavengers. The radicals then damage cell walls, reduce the flexibility of blood vessels, destroy enzymes, and cause other molecular damage...